Zobrazeno 1 - 10
of 540
pro vyhledávání: '"Kenneth W. Mahaffey"'
Autor:
Sean D, Pokorney, Glenn M, Chertow, Hussein R, Al-Khalidi, Dianne, Gallup, Pat, Dignacco, Kurt, Mussina, Nisha, Bansal, Crystal A, Gadegbeku, David A, Garcia, Samira, Garonzik, Renato D, Lopes, Kenneth W, Mahaffey, Kelly, Matsuda, John P, Middleton, Jennifer A, Rymer, George H, Sands, Ravi, Thadhani, Kevin L, Thomas, Jeffrey B, Washam, Wolfgang C, Winkelmayer, Christopher B, Granger
Publikováno v:
Circulation. 146:1735-1745
Background: There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial fibrillation (AF). Methods: The RENAL-AF trial (Renal Hemodialysis
Autor:
Ernest Spitzer, Alexander C. Fanaroff, C. Michael Gibson, Jonathan Seltzer, Eugene McFadden, Maria Ali, Matthew Wilson, Venu Menon, Roxana Mehran, Claes Held, Kenneth W. Mahaffey, Renato D. Lopes
Publikováno v:
American Heart Journal, 248, 120-129. Mosby Inc.
Background: Randomized clinical trials are the gold standard to assess the causal relationship between an intervention and subsequent outcomes, also known as clinical endpoints. In order to limit bias, central clinical events committees (CEC) are est
Autor:
Giulia Ferrannini, Carol Pollock, Andrea Natali, Yshai Yavin, Kenneth W. Mahaffey, Ele Ferrannini
Publikováno v:
Cardiovascular Diabetology. 22
Background Obesity is an independent risk factor for cardiovascular disease (CVD) in patients with type 2 diabetes (T2D). However, it is not known to what extent weight fluctuations might be associated with adverse outcomes. We aimed at assessing the
Autor:
NICHOLAS CAUWENBERGHS, FRANCOIS HADDAD, MELISSA A. DAUBERT, RANEE CHATTERJEE, MICHAEL SALERNO, JESSICA L. MEGA, PAUL HEIDENREICH, ADRIAN HERNANDEZ, MYRIAM AMSALLEM, YUKARI KOBAYASHI, KENNETH W. MAHAFFEY, SVATI H. SHAH, GERALD S. BLOOMFIELD, TATIANA KUZNETSOVA, PAMELA S. DOUGLAS
Publikováno v:
Journal of Cardiac Failure.
Autor:
Brendon L. Neuen, Megumi Oshima, Rajiv Agarwal, Clare Arnott, David Z. Cherney, Robert Edwards, Anna Maria Langkilde, Kenneth W. Mahaffey, Darren K. McGuire, Bruce Neal, Vlado Perkovic, Annpey Pong, Marc S. Sabatine, Itamar Raz, Tadashi Toyama, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Bernard Zinman, Hiddo J.L. Heerspink
Publikováno v:
Circulation, 145(19), 1460-1470. LIPPINCOTT WILLIAMS & WILKINS
Background: Hyperkalemia increases risk of cardiac arrhythmias and death and limits the use of renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor antagonists, which improve clinical outcomes in people with chronic kidney d
Autor:
Tina Baykaner, Krishna Pundi, Bryant Lin, Ying Lu, Katie DeSutter, Karma Lhamo, Gotzone Garay, Julio C. Nunes, Daniel P. Morin, Samuel F. Sears, Mina K. Chung, Michael K. Paasche-Orlow, Lee M. Sanders, Thomas Jared Bunch, Mellanie True Hills, Kenneth W. Mahaffey, Randall S. Stafford, Paul J. Wang
Publikováno v:
American Heart Journal. 247:68-75
Shared decision making (SDM) may result in treatment plans that best reflect the goals and wishes of patients, increasing patient satisfaction with the decision-making process. There is a knowledge gap to support the use of decision aids in SDM for a
Autor:
Paul J. Wang, Ying Lu, Kenneth W. Mahaffey, Amy Lin, Daniel P. Morin, Samuel F. Sears, Mina K. Chung, Andrea M. Russo, Bryant Lin, Jonathan Piccini, Mellanie True Hills, Caroline Berube, Krishna Pundi, Tina Baykaner, Gotzone Garay, Karma Lhamo, Eli Rice, Idean A. Pourshams, Rushil Shah, Paul Newswanger, Katie DeSutter, Julio Cesar Nunes, Michelle A. Albert, Kevin A. Schulman, Paul A. Heidenreich, T. Jared Bunch, Lee M. Sanders, Mintu Turakhia, Abraham Verghese, Randall S. Stafford
Publikováno v:
Journal of the American Heart Association. 12
Background Oral anticoagulation reduces stroke and disability in atrial fibrillation (AF) but is underused. We evaluated the effects of a novel patient‐clinician shared decision‐making (SDM) tool in reducing oral anticoagulation patient's decisio
Autor:
Rubina Attar, Angie Wu, Daniel Wojdyla, Svend Eggert Jensen, Pontus Andell, Kenneth W. Mahaffey, Matthew T. Roe, Stefan K. James, Lars Wallentin, Sreekanth Vemulapalli, John H. Alexander, Renato D. Lopes, E. Magnus Ohman, Adrian F. Hernandez, Manesh R. Patel, W. Schuyler Jones
Publikováno v:
Attar, R, Wu, A, Wojdyla, D, Jensen, S E, Andell, P, Mahaffey, K W, Roe, M T, James, S K, Wallentin, L, Vemulapalli, S, Alexander, J H, Lopes, R D, Ohman, E M, Hernandez, A F, Patel, M R & Jones, W S 2022, ' Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials) ', American Journal of Cardiology, vol. 178, pp. 11-17 . https://doi.org/10.1016/j.amjcard.2022.04.062
Patients with acute coronary syndrome (ACS) are at risk for recurrent adverse events, and multiple reports suggest that this risk is increased in patients with concomitant diabetes mellitus (DM) and peripheral artery disease (PAD). The aim of this ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4adfdd03c7027ca58f3d3c54dcd85098
https://vbn.aau.dk/da/publications/be7eeca3-2260-45f5-8424-8ccd86f3250b
https://vbn.aau.dk/da/publications/be7eeca3-2260-45f5-8424-8ccd86f3250b
Autor:
Meg Jardine, Norman Rosenthal, Megumi Oshima, Clare Arnott, Rajiv Agarwal, Luca De Nicola, Adeera Levin, Bruce Neal, Kenneth W. Mahaffey, David C. Wheeler, Christopher P. Cannon, David M. Charytan, José Luis Górriz, George L. Bakris, Hiddo J.L. Heerspink, Vlado Perkovic, Robert Edwards, Brendon L. Neuen, Carol A. Pollock
Publikováno v:
European Heart Journal, 42(48), 4891-4901. Oxford University Press
Aims Hyperkalaemia is a common complication of type 2 diabetes mellitus (T2DM) and limits the optimal use of agents that block the renin–angiotensin–aldosterone system, particularly in patients with chronic kidney disease (CKD). In patients with
Autor:
Gregg W. Stone, Charles Michael Gibson, Philippe Gabriel Steg, Ivar S Jensen, Khalid Salahuddin, Marc Claussen, Jayne Prats, Deepak L. Bhatt, Elizabeth Wu, Kenneth W. Mahaffey, Philip L. Cyr, Thomas Winkler
Publikováno v:
American Journal of Cardiovascular Drugs
Objectives The objective of this study was to evaluate a US hospital’s cost implications and outcomes of cangrelor use in percutaneous coronary intervention (PCI) patients with two or more angiographic high-risk features (HRFs), including avoidance